Zusammenfassung
Für die Pädiatrie klinisch wichtige Störungen des Lipidstoffwechsels umfassen Veränderungen der Plasmalipoproteine mit und ohne Hyperlipidämien, Lipidspeicherkrankheiten sowie Störungen der Fettsäureoxidation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Umrechnung in Stoffmengenkonzentration: mg/dl × 0,05551 = mmol/l.
Literatur
Amundsen AL, Ose L, Nenseter MS, Ntanios FY (2002) Plant sterol ester-enriched spread lowers plasma total and LDL cholesterol in children with familial hypercholesterolemia. Am J Clin Nutr 76: 338–344
Clauss S, Wai KM, Kavey RE, Kuehl K (2009) Ezetimibe treatment of pediatric patients with hypercholesterolemia. J Pediatr 154: 869–872
Davidson MH (2011) A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia. J Clin Lipidol 5:76–81
Descamps OS, Tenoutasse S, Stephenne X et al. (2011) Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis 218: 272–280
Eng CM, Guffon N, Wilcox WR et al. (2001) Safety and efficacy of recombinant human alpha-galactosidase A–replacement therapy in Fabry’s disease. N Engl J Med 345: 9–16
ESPGAN Committee on Nutrition (1994) Comment on childhood diet and prevention of coronary heart disease. J Pediatr Gastroenterol Nutr 19: 261–269
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). Adult Treatment Panel III. JAMA 285: 2486–2497
Farnier M, Bruckert E (2012) Severe familial hypercholesterolaemia: Current and future management. Arch Cardiovasc Dis 105: 656–665
Gotto AM Jr, Moon JE (2012) Management of cardiovascular risk: the importance of meeting lipid targets. Am J Cardiol 110 (1 Suppl): 3 A–14 A
Hallikainen MA, Sarkkinen ES, Uusitupa MI (2000) Plant stanol esters affect serum cholesterol concentrations of hypercholesterolemic men and women in a dose-dependent manner. J Nutr 130: 767–776
Jaeger BR, Tsobanelis T, Bengel F, Schwaiger M, Seidel D (2002) Long-term prevention of premature coronary atherosclerosis in homozygous familial hypercholesterolemia. J Pediatr 141: 125–128
Koletzko B, Ullrich K, Becker M, Beisiegel U, Schwandt P (1995) Diagnostik und Therapie der Hypercholesterinämie bei Kindern und Jugendlichen. Empfehlungen der Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen. Monatsschr Kinderheilkd 143: 1041–1042
Koletzko B, Dokoupil K, Schenk U von (1996) Hast Du auch hohes Cholesterin? Ein Ernährungsberater für Kinder und Eltern. Steinkopff, Darmstadt
LIPID Study Group (Long term Intervention with Pravastatin in-Ischaemic Disease) (2002) Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. Lancet 359: 1379–1387
Miettinen TA, Gylling H (1999) Regulation of cholesterol metabolism by dietary plant sterols. Curr Opin Lipidol 10: 9–14
Penson MG, Fricker FJ, Thompson JR et al. (2001) Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients. J Heart Lung Transplant 20: 611–618
Salen G, Bergmann K von, Lutjohann D et al.; Multicenter Sitosterolemia Study Group (2004) Ezetimibe effectively reduces plasma plant sterols in patients with sitosterolemia. Circulation 109: 966–971
Spiekerkoetter U, Lindner M, Santer R et al. (2009) Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis 32: 498–505
Winters JL (2011) Lipid apheresis, indications, and principles. J Clin Apher 26: 269–275
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Koletzko, B. (2014). Störungen des Lipid- und Lipoproteinstoffwechsels. In: Reinhardt, D., Nicolai, T., Zimmer, KP. (eds) Therapie der Krankheiten im Kindes- und Jugendalter. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-41814-3_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-41814-3_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-41813-6
Online ISBN: 978-3-642-41814-3
eBook Packages: Medicine (German Language)